MARY ANNE DELLA-FERA
Veterinary in Wahatoya, CO
License number
Pennsylvania BV004771L
Category
Veterinary Medicine
Type
Veterinarian
Address
Address
2
Wahatoya, CO 81055
Pennsylvania
Pennsylvania
Professional information
Xanthohumol Compositions And Methods Of Using Same
US Patent:
2009007, Mar 19, 2009
Filed:
Sep 12, 2008
Appl. No.:
12/209681
Inventors:
Clifton A. Baile - Athens GA, US
Mary Anne Della-Fera - La Veta CO, US
Hea Jin Park - Tolland CT, US
Srujana Rayalam - Athens GA, US
Mary Anne Della-Fera - La Veta CO, US
Hea Jin Park - Tolland CT, US
Srujana Rayalam - Athens GA, US
International Classification:
A61K 31/12, A61P 3/00, A61P 19/00, A61K 31/57, A61K 31/352
US Classification:
514171, 514456, 514685
Abstract:
The present invention provides compositions comprising an effective amount of xanthohumol and honokiol. The present invention comprises compositions comprising an effective amount of xanthohumol and genistein. The present invention comprises compositions comprising an effective amount of xanthohumol and guggulsterone. The compositions of the present invention may be effective to decrease mature adipocytes viability, induce apoptosis of mature adipocytes, increase lipolysis in mature adipocytes, and/or reduce adipogenesis during the maturation of pre-adipocytes. The present invention further provides methods of treating obesity, diabetes, osteoporosis or bone disorders in a subject, which comprise administering to the subject compositions comprising an effective amount of xanthohumol and honokiol, guggulsterone, or genistein.
Compositions And Methods For Inducing Adipose Tissue Cell Death
US Patent:
2004023, Nov 25, 2004
Filed:
May 14, 2004
Appl. No.:
10/845912
Inventors:
Clifton Baile - Athens GA, US
Mary Della-Fera - La Veta CO, US
Mary Della-Fera - La Veta CO, US
International Classification:
A61K031/4172
US Classification:
514/396000
Abstract:
Pharmaceutical compositions, methods for increasing the rate of apoptosis in adipose tissue cells, and methods of reducing adipose tissue mass in a host, are described. One exemplary pharmaceutical composition, among others, includes at least one catecholamine in combination with a pharmaceutically acceptable carrier. The catecholamine is present in a dosage level effective to increase the rate of apoptosis in adipose tissue cells in a host.